KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Shares Outstanding (Diluted Average) (2019 - 2025)

Rigel Pharmaceuticals has reported Shares Outstanding (Diluted Average) over the past 10 years, most recently at $18.8 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $18.8 million for Q4 2025, up 6.52% from a year ago — trailing twelve months through Dec 2025 was $18.8 million (up 6.52% YoY), and the annual figure for FY2025 was $18.8 million, up 6.52%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $18.8 million at Rigel Pharmaceuticals, up from $18.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for RIGL hit a ceiling of $176.1 million in Q1 2021 and a floor of $17.0 million in Q4 2022.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $18.3 million (2025), compared with a mean of $79.5 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): crashed 90.0% in 2022 and later increased 6.52% in 2025.
  • Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $170.5 million in 2021, then crashed by 90.0% to $17.0 million in 2022, then increased by 2.06% to $17.4 million in 2023, then grew by 1.64% to $17.7 million in 2024, then grew by 6.52% to $18.8 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $18.8 million (Q4 2025), $18.4 million (Q3 2025), and $18.2 million (Q2 2025) per Business Quant data.